Potential Drug Target/Biomarker for Olfactory Disorders (G127077)

Potential Drug Target/Biomarker for Olfactory Disorders

OR2T11, also known as olfactory receptor OR1-65, is a protein that is expressed in the olfactory system, which is responsible for the sense of smell. OR2T11 is a G protein-coupled receptor (GPCR), which means it is a transmembrane protein that is connected to the cell's intracellular signaling system.

The olfactory system is an essential part of the body's sense of smell. It is responsible for detecting and recognizing different scents, such as those from flowers, food, and drugs. The sense of smell is closely linked to the brain's reward system, and it plays a crucial role in our overall quality of life.

OR2T11 is one of the proteins that is involved in the olfactory system. It is a key receptor for the neurotransmitter olfactory neurotensin (ON), which is produced by the neurotransmitter system in response to the presence of scents. When ON binds to OR2T11, it triggers a signaling cascade that involves various downstream targets, including the G protein-coupled receptor GPR82.

GPR82 is a GPCR that is expressed in the brain and is involved in the regulation of various physiological processes, including sensory perception and behavior. It is thought to play a key role in the sense of smell by detecting and responding to specific scents.

OR2T11 is also known as olfactory receptor OR1-65 because it is one of the six olfactory receptors that are known to exist in the human body. The other five olfactory receptors are located on the surface of olfactory epithelial cells, and they are involved in the detection of different scents.

The identification and characterization of OR2T11 as a potential drug target or biomarker for olfactory disorders is an exciting area of 鈥嬧?媟esearch. Olfactory disorders are a group of conditions that are characterized by defects in the sense of smell. These disorders can range from mild to severe, and they can cause significant distress and quality of life.

One of the main challenges in the treatment of olfactory disorders is the lack of effective therapies that can specifically target the underlying molecular mechanisms. While there are some drugs that are available that can treat olfactory disorders, they are often broad-spectrum medications that have a variety of effects on multiple different physiological processes.

OR2T11 is thought to be a promising drug target for olfactory disorders because it is involved in the regulation of the olfactory system and is involved in the detection of specific scents. Additionally, because it is a GPCR and not a traditional GPCR, it may be more stable and less susceptible to some common side effects associated with traditional GPCRs.

In addition to its potential as a drug target, OR2T11 is also a potential biomarker for olfactory disorders. The ability to use OR2T11 as a biomarker could allow for the early detection and diagnosis of these disorders, which could have a significant impact on treatment outcomes.

OR2T11 is a transmembrane protein that is involved in the olfactory system. It is a GPCR and is thought to play a key role in the sense of smell. The identification and characterization of OR2T11 as a potential drug target or biomarker for olfactory disorders is an exciting area of 鈥嬧?媟esearch that could have a significant impact on the treatment of these disorders.

Protein Name: Olfactory Receptor Family 2 Subfamily T Member 11

Functions: Odorant receptor

The "OR2T11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2T11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5